🇺🇸 FDA

Company profile · Sponsor

Larimar

Larimar Therapeutics

LRMR · NYSE pharma BALA CYNWYD, PA, USA
Pipeline
3
Drugs
0
Patents
5

Quick answer

Larimar (LRMR) is a pharma company. headquartered in BALA CYNWYD, PA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 5 patents to this profile..

Company facts

Ticker LRMR
Exchange NYSE
Company type pharma
Headquarters BALA CYNWYD, PA, USA
SEC CIK 0001374690

Pipeline (3)

Search pipeline →

  1. Nomlabofusp, Placebo to Nomlabofusp

    Larimar

    Friedreich’s ataxia is the most common inherited ataxia in humans and results from a deficiency of the mitochondrial protein, FXN. Friedreich’s ataxia is a rare, progressive, multisystem disease with an incidence that is estimated to be 1:29,000, and a carrier frequency of ~1:85.

    phase 3 small molecule active

    1 trial

  2. CTI-1601

    Larimar

    Friedreich Ataxia

    phase 2 mab active

    4 trials

  3. Nomlabofusp

    Larimar

    Friedreich Ataxia

    phase 1 small molecule terminated

    1 trial

Patents (5)

Search patents →

  1. US 12390509

    Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12351611

    Molecules for organelle-specific protein delivery

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12091437

    Molecules for organelle-specific protein delivery

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11976100

    Methods for treating myelin associated diseases and mitochondria associated diseases

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11891420

    Molecules for organelle-specific protein delivery

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Larimar?

Larimar (LRMR) is a pharma company. headquartered in BALA CYNWYD, PA, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 5 patents to this profile..

What pipeline programs does Larimar sponsor?

We track 3 ClinicalTrials.gov-linked programs for Larimar, including Nomlabofusp, Placebo to Nomlabofusp and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Larimar company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.